Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott, NEA Show Medtech Deals Still Have Some Pop

This article was originally published in Start Up

Executive Summary

With a paucity of VC firms willing to invest in medtech companies, strategic players are being called upon to assume larger, more active roles in the process of starting and funding the start-ups that they may someday acquire. Last month, Abbott made a forceful move into the electrophysiology space with a trio of deals involving companies backed by New Enterprise Associates.

Advertisement

Related Content

New NEA Fund Could Bring $1 Billion To Health Care
Device/Diagnostics Quarterly Deal Statistics, Q4 2014
Medtech 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models
Medtech In 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models
Device Companies Follow New Map To Atrial Fibrillation

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT037939

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel